|
|
| 產(chǎn)品基本信息 |
|
| 產(chǎn)品編號(hào):E521555 |
| 產(chǎn)品名稱:EM20-25 |
| 產(chǎn)品CAS:141266-44-6 |
| 規(guī)格含量:25mg |
| 產(chǎn)品價(jià)格:面議 |
| 聯(lián)系我們: |
|
|
|
|
|
| 產(chǎn)品詳細(xì)介紹 |
| 標(biāo)準(zhǔn)品編號(hào): |
E521555 |
| 名稱: |
EM20-25 |
| 別名: |
5-?(6-?Chloro-?2,?4-?dioxo-?1,?3,?4,?10-?tetrahydro-?2H-?9-?oxa-?1,?3-?diaza-?anthracen-?10-?yl)?-?pyrimidine-?2,?4,?6-?trione; |
| CAS號(hào): |
141266-44-6 |
| 分子式: |
C??H?ClN?O? |
| 分子量: |
376.71 |
| 種類: |
Standards; Pharmaceutical/API Drug Impurities/Metabolites; |
| 應(yīng)用: |
EM20-25 is a disruptor of Bcl-2/BAX interactions. These disruptions occasionally have been seen to induce apoptosis in tumor cells. |
| 參考文獻(xiàn) |
|
|
|
|